Joseph Gut - thasso
Posted in Allelic Variant, Genetic Background, Genetic Predisposition, New Research, Nutrigenomics, Thasso Post, Theragenomic Medicine
No Comments ↓
January 30, 2022 – This was retrospectively seen information just in time for the holiday season. A new study in Scientific Reports on December 13 2021 comforts people who like to eat lots of black chocolate and to drink their coffee black too. These individuals do not need to worry;
…
Joseph Gut - thasso
Posted in Adverse Drug Reaction [ADR], New Safety Information, Regulatory Announcement, Thasso Post, Theragenomic Medicine
No Comments ↓
March 25, 2020 – The Covid-19 pandemic keeps the word abreast. Drastic measures have been and are being taken worldwide by governments, hospitals, healthcare care providers, and retiring homes in attempts to halt the spreading of Covid-19 disease. Recently, there have been publications by Chinese clinical researchers in the Journal Cell Research and the International Journal of Antimicrob Agents indicating that both,
…
Joseph Gut - thasso
Posted in New Research, On The Horizon, Personalized Medicine, Personomics, Targeted Therapy, Thasso Post, Theragenomic Medicine
No Comments ↓
July 26, 2019 – “Blockchains for secure digitized medicine”. This is the title of a very interesting and important article in the Journal of Personalised Medine (JPM) as of May 28, 2019.
Blockchain as an emerging technology (particularly around the hype on Bitcoins) has been gaining in popularity,
…
March 17, 2010 – The U.S. Food and Drug Administration (FDA) has added a Boxed Warning to the label for Clopidogrel [Plavix], the anti-blood clotting medication. The Boxed Warning is about patients who do not effectively metabolize the drug (i.e. “poor metabolizers”, see below) and therefore may not receive the full benefits of the drug.
…
Joseph Gut - thasso
Posted in Genetic Predisposition, Genetic Susceptibility, Personalized Medicine, Pharmacogenetics
No Comments ↓
January 16, 2010 – This contribution has just been published in the ScienceBlog – Pharmacogenetics at this locoation. It is presented here in its original state and with all credentials and rights resting with the original author.
Scientists at St. Jude Children’s Research Hospital have identified inherited variations in two genes that account for 37 percent of childhood acute lymphoblastic leukemia (ALL),
…
November 17, 2009 – Today, the US Food and Drug Administration (FDA) informed on new data showing that the proton pump inhibitor (PPI) Omeprazole [Prilosec] or [Prilosec OTC] reduces the anti-blood clotting effect of Clopidogrel [Plavix] by almost half when these 2 medicines are taken by the same patient.
…
Recent Comments